From shape-shifting to therapy
Shape-shifting in an ATP-dependent multidrug transporter involves formation of a tetrahelix bundle (in red and blue). Credit: Hendrik van Veen
(Medical Xpress)—The latest research into the intricate processes that let substances into and out of cells will help to lay the foundations for the next generation of therapies for major diseases.
A team based at the University of Cambridge's Department of Pharmacology has developed a means of tracking – and thus understanding – the processes by which multi-drug transporters deflect and eject substances from cells. Their work will form the basis for the development of new therapies to treat cancers and infectious diseases.
Each cell in our bodies – and every cell of every organism from bacteria upwards – is surrounded by a fatty layer called the cell membrane. This membrane acts as a molecular sieve that enables entry of vital nutrients, such as sugars, into the cell and allows exit of the garbage. The traffic of substances across the membrane is carried out by tiny molecular machines, known as transport proteins. These transport proteins ensure a healthy environment in the cell's interior, so that cells can live and make more cells.
But the picture is much more complex as there are several types of transport proteins. While most transporters are specialists and welcome particular substances, some others eject an extraordinarily broad range of substances from the cell. These so-called 'multi-drug transporters' are essential defense systems in all organisms ranging from bacteria to humans. They prevent the entry into the cell of toxic substances that are produced by our bodies or released by microorganisms competing for space and nutrients.
"As transport proteins, multi-drug transporters are responsible for producing chemotherapy resistance in cancers and pathogenic micro-organisms. When toxic drugs are used as part of anticancer and antimicrobial therapies, multi-drug transporters can impair the treatment of life-threatening disease," said Dr Hendrik van Veen at Cambridge's Department of Pharmacology.
An understanding of how multidrug transporters work is essential to getting a better grasp both of the roles of multi-drug transporters in the healthy functioning of cells, and how they can be stopped when things go wrong – for example when malicious cells invade our bodies.
Scientists have proposed since the 1950s that transport proteins work by switching their three-dimensional shape, using metabolic energy as fuel to alter their conformation in order to 'flip' molecules from inside the barrier of the cell membrane to the outside. However, the exact molecular basis of this switching has baffled researchers for some time.
Dr Hendrik van Veen and colleagues investigated the mechanism of molecular shape-shifting of a multi-drug transporter that uses the energy-carrying molecule ATP (adenosine triphosphate). They used genetic engineering to tweak a critical part of the transporter – a group of four helical structures embedded in the molecule (referred to as the tetrahelix bundle) that seems to act as a 'spring-lock' for the larger molecular structure of the protein.
He said: "Multidrug transporters operate by a mechanism in which parts of their structure responsible for binding of toxic drugs are first exposed to the inside of the cell, where they bind the drug, and then to the outside of the cell, where they release it. This mechanism relies on two defined shapes of the transporter, an inward-facing shape and an outward-facing shape. On the basis of three-dimensional structures of the transporter, we postulated that the tetrahelix bundle would be important for this shape-shifting."
By manipulating the sections of DNA that control the architecture of the multi-drug transporter, the researchers were able to produce bacteria that made altered versions of the transport protein. The researchers then built the modified proteins into 'inside-out'-oriented bubbles of cell membrane in which the transporters import the drug from the outside, thus making it easier to follow the transport process.
Dr van Veen and his team were able to show that both transport and the associated changes in protein conformation were greatly impaired by the structural alterations in the tetrahelix bundle, while other features, such as the transporter's ability to bind ATP and drugs, were not significantly affected. Because the activity of multi-drug transporters is critical in preventing the entry of anticancer agents and antimicrobial drugs into cells, this research lays the foundation for the development of agents that will block the 'spring-lock' of the transporter, thus rendering it powerless.
"Tetrahelix bundles are shared by all ATP-dependent multi-drug transport proteins and are essential for their activity. To use a metaphor, we're working on the development of sticks to put in the spokes to stop these wheels from turning, and the use of these sticks in a next generation of anticancer and antimicrobial therapies that will tackle the development of drug resistance," said Dr van Veen.
Provided by University of Cambridge
- Hot on the trail of metabolic diseases and resistance to antibiotics Mar 28, 2012 | not rated yet | 0
- ATP splitting in membrane protein dynamically measured for the first time Jul 11, 2012 | not rated yet | 0
- Technology reveals 'lock and key' proteins behind diseases Apr 12, 2007 | not rated yet | 0
- Crossing scientific boundaries to understand the rejection of drugs Dec 01, 2008 | not rated yet | 0
- Discovery could reduce chemotherapy's side effects Mar 11, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
New research from the University of Southampton has shown that blind and visually impaired people have the potential to use echolocation, similar to that used by bats and dolphins, to determine the location of an object.
Medical research 15 minutes ago | not rated yet | 0 |
A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference ...
Medical research 37 minutes ago | not rated yet | 0
Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. In his doctoral thesis Yue Shen from the Industrial ...
Medical research 5 hours ago | not rated yet | 0
When tumours metastasise, they can block lymphatic vessels, as researchers from ETH Zurich have discovered using a new method. The lymphatic fluid subsequently has to find a new path through the tissue. Such ...
Medical research 5 hours ago | not rated yet | 0 |
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
Medical research 23 hours ago | 5 / 5 (3) | 0 |
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) were twice as likely to be obese in a 33-year ...
59 minutes ago | not rated yet | 0 |
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
1 minute ago | not rated yet | 0
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...
37 minutes ago | not rated yet | 0
National guidelines recommend that at-risk women be screened for elevated cholesterol levels to reduce their chances of developing cardiovascular disease. But who is 'at risk?' The results of a study by investigators ...
33 seconds ago | not rated yet | 0
Women are less likely than men to receive care in a trauma center after severe injury, according to a new study of almost 100,000 Canadian patients.
1 hour ago | not rated yet | 0
Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location ...
3 hours ago | 5 / 5 (3) | 0 |